BARCLAYS PLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$24
-97.1%
1,580
-97.0%
0.00%
-100.0%
Q2 2023$814
-97.1%
51,836
-96.9%
0.00%
-92.3%
Q1 2023$27,856
+5.8%
1,690,341
+0.2%
0.01%
+8.3%
Q4 2022$26,320
-99.9%
1,687,141
-0.2%
0.01%
-50.0%
Q3 2022$21,919,000
-7.5%
1,690,041
+0.2%
0.02%
+71.4%
Q2 2022$23,685,000
-2.0%
1,686,9720.0%0.01%
-26.3%
Q1 2022$24,158,000
-38.5%
1,686,972
-41.5%
0.02%
+171.4%
Q4 2021$39,276,000
+61.8%
2,881,546
+94.5%
0.01%
-36.4%
Q3 2021$24,273,000
+37.6%
1,481,860
+41.4%
0.01%
+37.5%
Q2 2021$17,637,000
+9.4%
1,047,930
+18.7%
0.01%0.0%
Q1 2021$16,118,000
+32.2%
882,748
+31.8%
0.01%
+33.3%
Q4 2020$12,192,000
-16.6%
669,873
-18.3%
0.01%
-25.0%
Q3 2020$14,619,000
-0.7%
819,500
-0.2%
0.01%
-27.3%
Q2 2020$14,728,000
+9.3%
821,345
-7.4%
0.01%
+10.0%
Q1 2020$13,470,000
-31.6%
887,409
-11.0%
0.01%0.0%
Q4 2019$19,680,000
+14.4%
997,424
-0.3%
0.01%
-9.1%
Q3 2019$17,204,000
+10.8%
1,000,224
+14.0%
0.01%
+22.2%
Q2 2019$15,530,000
+9.0%
877,355
+25.5%
0.01%
-10.0%
Q1 2019$14,244,000
+3834.8%
699,192
+3151.9%
0.01%
Q4 2018$362,00021,5010.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders